|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities held to maturity (at fair value of $65,374,753 and $70,699,651 respectively) | ||||||||||||||||||||
| Securities held to maturity (fair value of $65,374,753 at December 31, 2023) | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $2,590,950 and $2,620,949, respectively | ||||||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $2,579,949 and $2,529,949, respectively | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") stock and other restricted securities | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Core deposit intangibles | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Investment in limited partnership | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Non-interest bearing deposits | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| FHLB advances-short term | ||||||||||||||||||||
| FHLB advances-long term | ||||||||||||||||||||
| Advance payments by borrowers for taxes and insurance | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock $0.01 par value 1,000,000 shares authorized, none issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock $0.01 par value, 30,000,000 shares authorized, 12,770,973 issued and outstanding at June 30, 2026 and 12,925,572 at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Unearned ESOP shares (416,491 shares at September 30, 2023 and 436,945 shares at December 31, 2022) | ||||||||||||||||||||
| Unearned ESOP shares (342,926 shares at June 30, 2026 and 356,188 shares at December 31, 2025) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
